Extendicare Inc.
EXETF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,466 | $1,305 | $1,222 | $1,167 |
| % Growth | 12.4% | 6.8% | 4.7% | – |
| Cost of Goods Sold | $0 | $1,137 | $1,145 | $1,051 |
| Gross Profit | $1,466 | $168 | $77 | $116 |
| % Margin | 100% | 12.8% | 6.3% | 9.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1,200 | $56 | $1,164 | $52 |
| SG&A Expenses | $1,200 | $56 | $1,164 | $52 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $155 | $156 | -$9 | $0 |
| Operating Expenses | $1,355 | $1,242 | $1,197 | $52 |
| Operating Income | $111 | $112 | $21 | $63 |
| % Margin | 7.6% | 8.6% | 1.7% | 5.4% |
| Other Income/Exp. Net | -$11 | -$67 | -$30 | -$36 |
| Pre-Tax Income | $100 | $45 | -$4 | $14 |
| Tax Expense | $25 | $11 | $0 | $6 |
| Net Income | $75 | $34 | $70 | $12 |
| % Margin | 5.1% | 2.6% | 5.7% | 1% |
| EPS | 0.92 | 0.4 | -0.053 | 0.13 |
| % Growth | 130% | 860.5% | -140.5% | – |
| EPS Diluted | 0.86 | 0.4 | -0.053 | 0.11 |
| Weighted Avg Shares Out | 89 | 85 | 89 | 90 |
| Weighted Avg Shares Out Dil | 95 | 85 | 89 | 90 |
| Supplemental Information | – | – | – | – |
| Interest Income | $7 | $6 | $5 | $2 |
| Interest Expense | $22 | $22 | $21 | $23 |
| Depreciation & Amortization | $33 | $32 | $32 | $39 |
| EBITDA | $155 | $99 | $49 | $75 |
| % Margin | 10.6% | 7.6% | 4% | 6.4% |